Cytogenetics in myelodysplastic syndromes

Kazuma Ohyashiki1, Atsushi Kodama, Junko H Ohyashiki

  • 1First Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan. ohyashiki@rr.iij4u.or.jp

Summary

Cytogenetic analysis is crucial for predicting prognosis and guiding treatment in myelodysplastic syndromes (MDS). Detecting chromosomal abnormalities, including numerical changes and uniparental disomy, improves patient management.